280 related articles for article (PubMed ID: 30232672)
1. Atypical clinical manifestations of Miller Fisher syndrome.
Jung JH; Oh EH; Shin JH; Kim DS; Choi SY; Choi KD; Choi JH
Neurol Sci; 2019 Jan; 40(1):67-73. PubMed ID: 30232672
[TBL] [Abstract][Full Text] [Related]
2. [Ataxia with ophthalmoplegia: Miller-Fisher syndrome with anti-GQ1b antibody positivity].
Guilloton L; Camarasa C; Agard E; Tondeur G; Dot C; Drouet A
J Fr Ophtalmol; 2014 Feb; 37(2):89-92. PubMed ID: 24513384
[TBL] [Abstract][Full Text] [Related]
3. Headache and Ophthalmoparesis: Case Report of an "Atypical" Incomplete Miller-Fisher Syndrome.
Moreno-Ajona D; Irimia P; Fernández-Matarrubia M
Headache; 2018 May; 58(5):746-749. PubMed ID: 29878345
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization of anti-GQ1b antibody syndrome in Korean children.
Yoon L; Kim BR; Kim HY; Kwak MJ; Park KH; Bae MH; Lee Y; Nam SO; Choi HY; Kim YM
J Neuroimmunol; 2019 May; 330():170-173. PubMed ID: 30642576
[TBL] [Abstract][Full Text] [Related]
5. A case of Miller Fisher syndrome with anti GQ1b in Thailand.
Sawanyawisuth K; Tiamkao S; Jitpimolmard S; Vincent A
J Med Assoc Thai; 2007 Feb; 90(2):391-3. PubMed ID: 17375649
[TBL] [Abstract][Full Text] [Related]
6. Complete bilateral ophthalmoplegia with unilateral facial palsy in a child with anti-GQ1b syndrome.
Kauser H; Jain P; Sharma S; Aneja S
Indian J Pediatr; 2015 Feb; 82(2):192-4. PubMed ID: 24997143
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients.
de Bruyn A; Poesen K; Bossuyt X; Heremans IP; Claeys T; Depuydt CE; Van Damme P; Claeys KG
Acta Neurol Belg; 2019 Mar; 119(1):29-36. PubMed ID: 30747336
[TBL] [Abstract][Full Text] [Related]
8. Delayed facial palsy in Miller Fisher syndrome.
Tan CY; Yuki N; Shahrizaila N
J Neurol Sci; 2015 Nov; 358(1-2):409-12. PubMed ID: 26277343
[TBL] [Abstract][Full Text] [Related]
9. Anti-GQ1b antibody syndrome presenting as acute isolated bilateral ophthalmoplegia: Report on two patients and review of the literature.
Guisset F; Ferreiro C; Voets S; Sellier J; Debaugnies F; Corazza F; Deconinck N; Prigogine C
Eur J Paediatr Neurol; 2016 May; 20(3):439-43. PubMed ID: 26924168
[TBL] [Abstract][Full Text] [Related]
10. Acute bilateral mydriasis associated with anti-GQ1b antibody.
Fleury V; Aqallal A; Lagrange E; Besson G; Caudie C
J Clin Neurosci; 2010 Apr; 17(4):514-5. PubMed ID: 20093031
[TBL] [Abstract][Full Text] [Related]
11. Ocular Manifestations of Miller Fisher Syndrome: a Case Report.
Ravlic MM; Knezevic L; Krolo I; Herman JS
Med Arch; 2021 Jun; 75(3):234-236. PubMed ID: 34483456
[TBL] [Abstract][Full Text] [Related]
12. Miller Fisher syndrome with early intracranial hypertension and delayed bilateral simultaneous facial nerve palsy: a case report.
Liu YM; Chen YL; Deng YH; Liang YL; Li W; Chen J
J Int Med Res; 2020 Mar; 48(3):300060519867490. PubMed ID: 31709869
[TBL] [Abstract][Full Text] [Related]
13. [Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination].
Blanco-Marchite CI; Buznego-Suárez L; Fagúndez-Vargas MA; Méndez-Llatas M; Pozo-Martos P
Arch Soc Esp Oftalmol; 2008 Jul; 83(7):433-5. PubMed ID: 18592444
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies.
Alijanzadeh D; Soltani A; Afra F; Salmanpour F; Loghman AH; Samieefar N; Rezaei N
BMC Neurol; 2023 Sep; 23(1):332. PubMed ID: 37735648
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and prognosis of Miller Fisher syndrome.
Mori M; Kuwabara S; Fukutake T; Yuki N; Hattori T
Neurology; 2001 Apr; 56(8):1104-6. PubMed ID: 11320188
[TBL] [Abstract][Full Text] [Related]
16. [Anti-GQ1b antibodies: usefulness of its detection for the diagnosis of Miller-Fisher syndrome].
Rojas-García R; Gallardo E; Serrano-Munuera C; de Luna N; Ortiz E; Roig C; Grau-Veciana JM; Illa I
Med Clin (Barc); 2001 Jun; 116(20):761-4. PubMed ID: 11440679
[TBL] [Abstract][Full Text] [Related]
17. The Differential Diagnosis of Acute Onset Truncal Ataxia: The Importance of Dysgeusia in Miller Fisher Syndrome.
Ueno T; Kimura R; Kon T; Haga R; Nishijima H; Nunomura JI; Tomiyama M
Intern Med; 2018 Jul; 57(14):2057-2060. PubMed ID: 29491292
[TBL] [Abstract][Full Text] [Related]
18. Development of facial palsy during immunoadsorption plasmapheresis in Miller Fisher syndrome: a clinical report of two cases.
Chida K; Takase S; Itoyama Y
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):399-401. PubMed ID: 9527160
[TBL] [Abstract][Full Text] [Related]
19. Ataxia and ophthalmoplegia: an atypical case of Miller Fisher syndrome (MFS) with anti-GAD antibody.
Shoraka AR; Fang X; Hamouda D; Gogia B; Li X
Int J Neurosci; 2022 Oct; 132(10):994-998. PubMed ID: 33280463
[TBL] [Abstract][Full Text] [Related]
20. Progressive subacute Miller-Fisher syndrome successfully treated with plasmapheresis.
Ejma M; Waliszewska-Prosół M; Hofman A; Budrewicz S; Podemski R; Bilińska M; Koszewicz M
Neurol Neurochir Pol; 2015; 49(2):137-8. PubMed ID: 25890931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
